AlphaFold predicted structure
TPP2 · P29144

Mean pLDDT
91.9/ 100
Very high
1,249 residues
Confidence breakdown
- Very high(≥ 90)80%
- Confident(70–90)16%
- Low(50–70)1%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
tripeptidyl peptidase 2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalAdult onset leukodystrophy
BIALLELIC, autosomal or pseudoautosomalimmunodeficiency 78 with autoimmunity and developmental delay
Evans syndrome
neurodegenerative disease
Global developmental delay
Autoimmunity
atrial fibrillation
Recurrent upper respiratory tract infections
Thrombocytopenia
Cutis marmorata
Recurrent lower respiratory tract infections
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Tripeptidyl-peptidase 2
Cytosolic tripeptidyl-peptidase that releases N-terminal tripeptides from polypeptides and is a component of the proteolytic cascade acting downstream of the 26S proteasome in the ubiquitin-proteasome pathway (PubMed:25525876, PubMed:30533531). It plays an important role in intracellular amino acid homeostasis (PubMed:25525876). Stimulates adipogenesis (By similarity)
TPP2 · P29144

Mean pLDDT
91.9/ 100
Very high
1,249 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0